Chromobox 2 (CBX2), a component of polycomb repressive complex 1 (PRC1), binds lysine 27methylated histone H3 (H3K27me3) via its chromodomain (CD) and plays a critical role in repressing developmentally regulated genes. The phosphorylation of CBX2 has been described in several studies, but the biological implications of this modification remain largely elusive. Here, we show that CBX2's phosphorylation plays an important role in its nucleosome binding. CBX2 is stably phosphorylated in vivo, and domain analysis showed that residues in CBX2's serine-rich (SR) region are the predominant phosphorylation sites. The serine residues in an SR region followed by an acidicresidue (AR) cluster coincide with the consensus target of casein kinase II (CK2), and CK2 efficiently phosphorylated the SR region in vitro. A nucleosome pulldown assay revealed that CK2-phosphorylated CBX2 had a high specificity for H3K27me3-modified nucleosomes. An electrophoretic mobility-shift assay showed that CK2-mediated phosphorylation diminished CBX2's AT-hookassociated DNA-binding activity. Mutant CBX2 lacking the SR region or its neighboring AR cluster failed to repress the transcription of p21, a gene targeted by PRC1. These results suggest that CBX2's phosphorylation is critical for its transcriptional repression of target genes.
Chromobox 2 (CBX2), a component of polycomb repressive complex 1 (PRC1), binds lysine 27methylated histone H3 (H3K27me3) via its chromodomain (CD) and plays a critical role in repressing developmentally regulated genes. The phosphorylation of CBX2 has been described in several studies, but the biological implications of this modification remain largely elusive. Here, we show that CBX2's phosphorylation plays an important role in its nucleosome binding. CBX2 is stably phosphorylated in vivo, and domain analysis showed that residues in CBX2's serine-rich (SR) region are the predominant phosphorylation sites. The serine residues in an SR region followed by an acidicresidue (AR) cluster coincide with the consensus target of casein kinase II (CK2), and CK2 efficiently phosphorylated the SR region in vitro. A nucleosome pulldown assay revealed that CK2-phosphorylated CBX2 had a high specificity for H3K27me3-modified nucleosomes. An electrophoretic mobility-shift assay showed that CK2-mediated phosphorylation diminished CBX2's AT-hookassociated DNA-binding activity. Mutant CBX2 lacking the SR region or its neighboring AR cluster failed to repress the transcription of p21, a gene targeted by PRC1. These results suggest that CBX2's phosphorylation is critical for its transcriptional repression of target genes.
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Abbreviations: AR, acidic residue; AT, AT-hook; ATL, AT-hook like; CBX, chromobox; CD, chromodomain; CK2, casein kinase II; EMSA, electrophoretic mobility-shift assay; Pc, Polycomb; PcG, Polycomb-group; PRC, polycomb repressive complex; SAP, shrimp alkaline-phosphatase; SR, serine-rich; TrxG, Trithorax-group. Precise transcriptional regulation is critical for determining cell fates during development. Polycomb-group (PcG) and Trithorax-group (TrxG) proteins were identified in Drosophila melanogaster as repressors and activators of Hox genes, respectively, during early development. Subsequent studies demonstrated that PcG proteins regulate gene expression in diverse biological processes (1, 2) . Most PcG proteins can be divided into two groups, which form distinct protein complexes called polycomb repressive complex 1 (PRC1) and 2 (PRC2). PRC2 catalyzes the methylation of histone H3 on K27, while PRC1 ubiquitylates histone H2A on K119 (H2AK119ub) and compacts chromatin (27) . Polycomb (Pc), a core subunit of PRC1 that contains a chromodomain (CD), binds the trimethylated H3K27 (H3K27me3) provided by PRC2, which in turn recruits the entire PRC1 complex to form repressive chromatin (710). Recent studies identifying non-canonical variant PRC1 (vPRC1) complexes in mammalian cells suggest an alternative mechanism, in which vPRC1 complexes target chromatin independently of H3K27me3, and H2AK119ub provided by vPRC1 recruits PRC2 (11, 12) .
Flies have one Pc, whereas mammalian cells express five Pc homologues (CBX2, CBX4, CBX6, CBX7 and CBX8). These proteins contain a CD at their amino (N)-terminus, and are thus collectively termed chromobox (CBX) proteins (1, 13) . Although the CBX proteins include three Drosophila heterochromatin protein 1 (dHP1) homologues (CBX1, CBX3 and CBX5), references to CBX proteins henceforward refer specifically to the five mammalian Pc homologues. Of the mammalian CBX proteins, CBX2 (also known as M33) was the first known functional Drosophila Pc homologue (14) . In addition to the N-terminal CD, CBX proteins also share a carboxyl (C)-terminal polycomb repressor box (PcBox), which mediates interactions with Ring1 family proteins (13) . Since each CBX protein has a distinct expression pattern during development, these proteins may have non-overlapping functions (1517). While CBX proteins bind H3K27me3 via the CD, this binding affinity is weak compared with that of HP1 proteins targeting K9-trimethylated histone H3 (H3K9me3) (9, 18) . Therefore, it has been suggested that CBX proteins use other means to stably bind chromatin (9) . Consistent with this idea, CBX7's ability to bind both nucleic acids and H3K27me3 is critical for its chromatin binding (1820). While the CD is vital to the function of CBX proteins, and many studies have analyzed the CD alone, it is also important to consider the functional involvement of other domains in the CBX proteins' chromatin-binding mechanisms (9, 2123).
CBX2 regulates the expression of numerous genes, including those controlling embryonic development, sexual determination, stem-cell differentiation, tumorigenesis and cell cycle and growth (16, 2428) . In addition to the CD and PcBox domains, CBX2 possesses several unique motifs that are conserved across vertebrates (Fig. 1A) (13, 29) . Recent studies demonstrated that CBX2's N-terminus is required for targeting CBX2 to chromatin in the early mouse embryo and in mitotic chromosomes of cultured human cells (B) Phosphorylation patterns of human CBX2. HEK293T whole-cell lysates were resolved by SDS-PAGE, and endogenous CBX2 was detected by western blotting using an anti-CBX2 antibody (top). An anti-a-tubulin antibody was used as a loading control (bottom). SAP-treated samples were used as unphosphorylated basal control proteins. * indicates the band for SAP, which cross-reacted with the anti-CBX2 antibody; ** indicates nonspecific protein bands. (C) Phosphorylation patterns of transiently expressed FLAG-CBX2 protein in HEK293T cells, analyzed by western blotting using an anti-FLAG antibody (top). An anti-a-tubulin antibody was used as a loading control (bottom). (D) Phosphorylation patterns of FLAG-tagged wild-type and mutant CBX2 proteins. (illustrated at top). FLAG-CBX2 proteins and tubulin (control) in HEK293T cells were detected by western blots using anti-FLAG and anti-a-tubulin antibodies, respectively (bottom panels). (E) Phosphorylation patterns wild-type and mutant FLAG-tagged CBX2 N-terminus (FLAG-CBX2-N) proteins (illustrated at top) transiently expressed in HEK293T cells. FLAG-CBX2-N proteins and tubulin (control) were detected by western blotting using anti-FLAG and anti-a-tubulin antibodies, respectively, (bottom panels). (30, 31) . Another study showed that CBX2 can compact chromatin, and that a positively charged feature of CBX2 is critical for this activity (32) . The mechanisms that functionally link these regions with the CD's H3K27me3 binding remain largely unknown.
There is growing evidence that the targeting of chromatin proteins can be regulated by posttranslational modifications (33) . In mammalian cells, CBX2 undergoes phosphorylation, and a study using mouse tissue showed that this modification is coupled with CBX2's nuclear translocation (34) . Another study identified candidate phosphorylation sites in mouse Cbx2 and demonstrated that phosphorylation within the CD affects Cbx2's binding specificity for methylated histone H3 peptide (35) . Although the kinases responsible for CBX2 phosphorylation have not been identified, a proteomic survey of molecules that interact with CBX proteins identified casein kinase II (CK2) (36) , suggesting its involvement in CBX2's function. We previously showed that CK2 phosphorylates HP1a at its N-terminal serine residues, thereby suppressing HP1a's intrinsic DNA-binding activity and increasing its nucleosome-binding specificity (37, 38) . Although CBX2 has a DNA-binding module called an AThook near the CD, the overall effect of phosphorylation on CBX2's function remains unclear.
In this study, we found that CBX2's phosphorylation plays a critical role in its nucleosome binding. Using cultured human cells, we demonstrated that CBX2 is stably phosphorylated in vivo and that its serine-rich (SR) region contains the major phosphorylation sites. We also showed that phosphorylation at the SR region increased CBX2's binding specificity for H3K27me3-marked nucleosomes. Mutant CBX2 proteins lacking the SR region or its neighboring acidic residue (AR) cluster failed to restore the transcriptional silencing of p21, a PRC1 target gene. These results highlight an intriguing relationship among the CD, the adjacent DNA-binding modules, and phosphorylation that is associated with chromatin targeting.
Materials and Methods
Cell culture and transfection HEK293T cells were cultured in Dulbecco's Modified Eagle's Medium (Nacalai Tesque) supplemented with 10% fetal bovine serum (Gibco). Plasmids and siRNAs were introduced into HEK293T cells using Lipofectamine 3000 (Invitrogen) and Lipofectamine RNAiMAX (Invitrogen) reagents, respectively.
Plasmid construction
Complementary DNAs (cDNAs) for human CBX2 were amplified by polymerase chain reaction (PCR) from a HEK293T-cell cDNA library using the Pfu Turbo PCR system (Agilent). The PCR products were cloned into the pCRII-TOPO vector with the TOPO-TA Cloning Kit (Invitrogen), sequenced, and subcloned into each expression plasmid. To produce glutathione S-transferase (GST)-fused recombinant CBX2 (GST-CBX2) proteins, the corresponding CBX2 cDNAs were introduced into the pGEX6P-3 vector (GE Healthcare). To express FLAG-tagged full-length or C-terminally truncated CBX2 proteins in HEK293T cells, the corresponding cDNAs were introduced into pFLAG-C1 (37) to obtain pFLAG-CBX2. Mutagenesis was performed using KOD Plus (Toyobo).
Purification of recombinant proteins
Recombinant GST-CBX2 proteins were produced in E. coli BL21 (DE3) cells and purified using Glutathione Sepharose 4B (GE Healthcare) according to the manufacturer's instructions. The GST-CBX2 proteins were further purified by anion-exchange chromatography (SOURCE 15Q; GE Healthcare). To produce phosphorylated GST-CBX2 proteins, each GST-CBX2expressing plasmid was introduced simultaneously with the pRSFDuet-CK2 plasmid (37) into E. coli BL21 (DE3) cells. E. coli cells harboring both plasmids were selected with medium containing ampicillin (for pGEX-6P-3-derived plasmids) and kanamycin (for pRSFDuet-CK2). Phosphorylated GST-tagged proteins were also purified using Glutathione Sepharose 4B as described above.
Electrophoretic mobility-shift assays (EMSAs) EMSAs were performed as described previously (39) . Briefly, a 130-bp major satellite DNA fragment was amplified by PCR and used as a double-strand-DNA (dsDNA) probe. To produce a single-strand-RNA (ssRNA) probe, the major satellite DNA fragment was PCRamplified with the T7 promoter sequence and transcribed in vitro using Thermo T7 RNA polymerases (Toyobo). The transcribed RNA was purified on denaturing polyacrylamide gel containing 7 M urea and extracted with Biomasher I (Assist). The purified major satellite ssRNA and dsDNA were labeled with the 5' EndTag Nucleic Acid Labeling System (Vector Laboratories). The labeled probes were incubated with GST-CBX2 proteins in 10 ml of binding buffer (20 mM HEPES-KOH [pH 7.6], 100 mM KCl, 0.01% NP-40 and 1 mM dithiothreitol [DTT]) containing 4 U RNaseOUT (Invitrogen). Binding reactions were carried out on ice for 30 min. Titration EMSAs used 1:2 serially diluted GST-CBX2 proteins. Samples were loaded onto 5% polyacrylamide gel with 0.5Â TrisBorate-EDTA (TBE), and labeled probes were detected with the Typhoon 9400 (GE Healthcare). The unbound fractions were measured with the ImageMaster 1D software (GE Healthcare), and curve fitting was performed with Igor Pro software (WaveMetrics).
Phosphorylation assays
In vitro phosphorylation assays were performed as described previously (37) . For each recombinant GST-CBX2 protein, 1 mg was incubated with 100 U recombinant casein kinase II (CK2; NEB) in 25 ml reaction buffer (20 mM Tris-HCl [pH 7.5], 50 mM KCl, 10 mM MgCl 2 and 200 mM adenosine triphosphate [ATP]) for 3 h at 30 C. For in vitro de-phosphorylation assays, pFLAG-CBX2 plasmids were transfected into HEK293T cells. After 48 h, the cells were harvested and lysed in RIPA buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate and 0.1% sodium dodecyl sulfate [SDS]) supplemented with 10 mM sodium fluoride (NaF) and protease inhibitor cocktail (Complete, EDTA-free, Roche). Lysed cells were diluted with an isovolume of 2Â alkalinephosphatase reaction buffer (50 mM Tris-HCl [pH 9.0] and 5 mM MgCl 2 ) and incubated with 160 U/ml shrimp alkaline phosphatase (SAP, TaKaRa) for at least 3 h at 37 C. After incubation, the samples were boiled with SDS sample buffer, resolved by SDS-PAGE, and visualized by Coomassie Brilliant Blue (CBB) staining.
Peptide pull-down assays Peptide pull-down assays were performed as described previously (37) with some modifications. Unmodified and K27me3 histone H3 peptides (18$33 aa) were synthesized with C-terminal cysteine residues and crosslinked with Sulfolink Coupling Resin (Pierce), and 50 nmol of peptides were incubated with 500 ml (bed volume) of beads for at least 5 h at room temperature. Next, 5 pmol of recombinant CBX2 proteins were incubated with 50 ml of beads corresponding to 5 nmol of crosslinked peptides (protein:peptide ratio 1:1,000) in 150 ml of binding buffer (20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA and 0.1% Triton X) for 1 h at room temperature. The beads were then washed three times with 1 ml of binding buffer. The pulled-down proteins were eluted by boiling with SDS sample buffer, resolved by SDS-PAGE and analyzed by western blotting using anti-GST antibodies.
Nucleosome pull-down assays Nucleosome reconstitution and pull-down assays were performed as described previously (38, 40) . Briefly, 1 mg of nucleosomes (H3Kc27me3 or unmodified H3 nucleosomes) was incubated with T1 beads (Invitrogen) in binding buffer (10 mM Tris-HCl [pH7.5], CBX2 phosphorylation and its chromatin binding 150 mM NaCl, 0.1% Triton X, 5% glycerol, 0.025 mM EDTA, 0.1 mg/ml bovine serum albumin [BSA] and 1 mM DTT) for 4 h at 4 C, after which the beads were washed twice with binding buffer. Next, 100 pmol of GST or GST-CBX2 protein was pulled down by incubation with the nucleosome-bound beads in binding buffer for 1 h at 4 C, after which the beads were washed three times with wash buffer (10 mM Tris-HCl [pH 7.5], 300 mM NaCl, 0.1% Triton-X, 5% glycerol and 0.025 mM EDTA). The pulled-down GST or GST-CBX2 proteins were eluted by boiling with SDS sample buffer, resolved by SDS-PAGE and detected by western blotting using anti-GST antibodies.
CBX2 knockdown and rescue experiments siRNAs were introduced into HEK293T cells using RNAiMAX reagents (Invitrogen). After 72 h, the siRNA-treated cells were harvested and subjected to western blotting using an anti-CBX2 antibody. For knockdown-rescue experiments, control plasmids or plasmids encoding pFLAG-CBX2 or mutant CBX2 were transfected into siRNA-treated HEK293T cells, and the cells were harvested after 72 h and used for western blotting and quantitative RT-PCR. For western blotting, the harvested cells were boiled in SDS sample buffer and resolved by SDS-PAGE. The FLAG-CBX2 proteins were detected by western blotting using an anti-FLAG antibody. The following siRNAs were used in this study: siCBX2-3 0 UTR (cocktail),
and 5 0 -AGACCAACAAGGCAGUGAGTT-3 0 . Control siRNA was purchased from Cosmo Bio.
RNA extraction and quantitative real-time reverse transcription (RT)-PCR analysis
Total RNA was extracted from HEK293T cells using Trizol Reagent (Invitrogen). Extracted total RNA was treated with 2.5 U DNase I (Takara) in 50 ml DNase buffer (40 mM Tris-HCl [pH 7.5], 8 mM MgCl 2 , and 5 mM DTT) for 20 min at 37 C. Quantitative RT-PCR was performed using the Power SYBR Green RNA-to-Ct 1-
Step Kit (Applied Biosystems) and the StepOnePlus Real Time PCR system (Applied Biosystems). Each RT-PCR value was normalized to human -ACTIN mRNA.
Antibodies
The following antibodies were used in this study: anti-CBX2 (ab80044; Abcam), anti-a-tubulin (T5168; Sigma), horseradish peroxidase (HRP)conjugated anti-FLAG M2 (A8592; Sigma), HRPconjugated anti-rabbit immunoglobulin G (A6667; Sigma) and HRP-conjugated anti-histone H3 (ab21054; Abcam). Anti-GST rabbit polyclonal antibodies were raised and affinity-purified using recombinant GST (39) .
Results

CBX2's N-terminal SR region is phosphorylated in vivo
To investigate CBX2's chromatin-targeting mechanisms, we first analyzed its phosphorylation state in human 293T cells by western blotting with an anti-CBX2 antibody. While the expected molecular mass of CBX2 is about 56 kDa, we detected a major band at around 73 kDa in an SDS-PAGE gel (Fig. 1B) , and this band shifted to a faster-migrating band after shrimp alkaline-phosphatase (SAP) treatment (Fig. 1B, SAP+) . We confirmed CBX2's phosphorylation state by analyzing ectopically expressed FLAGtagged CBX2 (FLAG-CBX2) (Fig. 1C) , which was detected at a position similar to that of endogenous CBX2 (Fig. 1B) ; this band also shifted to a fastermigrating band after SAP treatment. These results agree with previous observations (34, 35) and suggest that CBX2 is constitutively phosphorylated in vivo.
Several phosphorylated peptides have been identified within CBX2 by mass spectrometric analysis, and the involvement of serine 42 (S42) in CD's recognition of methylated H3 peptide was demonstrated in vitro (35) . However, the physiological roles of these candidate phosphorylation sites remain elusive. When we examined the potential phosphorylation sites on CBX2, we noticed that the SR region followed by an AR cluster fits well with CK2's consensus target sequence (SXXE/D, SXE/D, SD) (Fig. 1A) (41) , which is reminiscent of the N-terminal region of HP1a (37, 38) . Although the serine cluster's position relative to the CD is opposite to that in HP1a, it is possible that the SR region is also phosphorylated by CK2 and modulates the function of CBX2's CD.
To test this possibility, we prepared constructs that expressed FLAG-CBX2 lacking the SR region or AR cluster, as well as FLAG-CBX2 that contained an S42A mutation, and analyzed changes in these proteins' migration in SDS-PAGE gel after SAP treatment. While the S42A mutation had little or no effect on the overall migration pattern of control and SAP-treated FLAG-CBX2 (Fig. 1D, WT and S42A ), a deletion of the SR region (ÁSR) or AR cluster (ÁAR) noticeably reduced the difference in migration between control (SAP À ) and SAP-treated (SAP + ) FLAG-CBX2 (Fig. 1D , ÁSR and ÁAR), suggesting that the SR region is a major phosphorylation site within CBX2 and that the adjacent AR cluster contributes to CBX2's phosphorylation at the SR region.
To further clarify CBX2's phosphorylation state, we examined the effect of the ÁSR, ÁAR and S42A mutations on the migration of the FLAG-tagged N-terminal region (1$129 aa) of CBX2 (FLAG-CBX2-N) after SAP treatment. While full-length FLAG-CBX2 was detected as one major band (Fig. 1C and D) , FLAG-CBX2-N was detected as at least two distinct bands: a faster-migrating major band and a slowermigrating minor band (Fig. 1E , WT, SAP À ). Since both of these bands shifted to faster-migrating bands while maintaining their relative position after SAP treatment (Fig. 1E , WT, SAP + ), the slower-migrating band might contain an additional SAP-resistant phosphorylation or a modification other than phosphorylation. The S42A mutation did not affect the overall pattern of the FLAG-CBX2-N bands (Fig. 1E, S42A , SAP À ). Although the position of the fastest band after SAP treatment was comparable to that of WT, the band pattern after SAP treatment differed from that of WT FLAG-CBX2-N, and it appeared that SAP partially removed the phosphorylation. The reason for this effect was unclear, but S42A might change the overall structure of CBX2-N and affect the SAP activity. Interestingly, ÁSR shifted FLAG-CBX2-N's migration and SAP treatment did not change the overall pattern (Fig. 1E, ÁSR) . ÁAR also changed FLAG-CBX2-N's migration pattern; the position of the fastest-migrating band was similar before and after SAP treatment (Fig. 1E, ÁAR) , but several bands containing phosphorylation were also clearly detected. Together, these results suggested that the SR region contains CBX2's major phosphorylation sites, and that the AR cluster following the SR region contributes to this phosphorylation.
While CBX2 phosphorylation at S42 was identified in a previous study, the S42A mutation did not noticeably affect the migration pattern of full-length CBX2 (Fig. 1D) or of CBX2-N (Fig. 1E) , suggesting that phosphorylation at this site makes only a minor contribution to the CBX2 phosphorylation detected by a migration change on SDS-PAGE. While ÁSR almost completely abolished the phosphorylation of FLAG-CBX2-N (1-129 aa) (Fig. 1E) , a clear band shift was observed for full-length FLAG-CBX2ÁSR after SAP treatment (Fig. 1D) , suggesting that CBX2's C-terminal region contains additional phosphorylation site(s). Since a previous study identified a phosphorylated peptide containing serine residues that fit with the CK2 consensus sequence (438-484 aa) (35) , it is likely that some of these serine residues were also phosphorylated by CK2 in vivo.
CK2-mediated phosphorylation modulates CBX2-CD's binding of H3K27me3 peptides
We next examined whether CBX2's SR region could be phosphorylated by CK2 in vitro. GST-fused recombinant proteins for CBX2-CD, CBX2-CD with the AThook (CBX2-CD + AT) and CBX2-N (containing the SR region and AR cluster) ( Fig. 2A) were incubated with CK2 and analyzed by SDS-PAGE. While some minor phosphorylated bands were detected for CBX2-CD and CBX2-CD + AT, the major bands for these recombinant proteins were unchanged after CK2 incubation (Fig. 2B , CD and CD + AT). However, the major band for CBX2-N shifted to slower-migrating bands after incubation with CK2 (Fig. 2B, CBX2-N) , suggesting that the SR region was efficiently phosphorylated by CK2 in vitro.
To test whether CK2-mediated phosphorylation affects CBX2-CD's function, we prepared phosphorylated CBX2-N using an E. coli co-expression system (Fig. 2C) (37) and performed a peptide pull-down assay using beads crosslinked with unmodified or K27-trimethylated H3 peptide (18$33 aa). As previously observed (9, 18), CBX2-CD preferentially bound the H3K27me3 peptide and bound only negligibly to the unmodified H3 peptide (Fig. 2D) . Interestingly, CBX2-CD + AT and CBX2-N showed little or no preference for the H3K27me3 peptide, indicating that neighboring regions, most likely the AThook motif, interfered with the CBX2-CD's binding to H3K27me3. Although a previous NMR study showed that the AT-hook region does not interact with free H3K27me3 peptide (30), this negative effect was probably due to an electrostatic interaction between the AT-hook and the H3 peptide. Even more interestingly, CK2-mediated phosphorylation partially restored CBX2-N's preference for binding the H3K27me3 peptide (Fig. 2D, CBX2-N + phos) . These results suggested that CK2-mediated phosphorylation at CBX2's SR region contributes to the CBX2-CD's recognition of H3K27me3.
CK2-mediated phosphorylation increases CBX2N's nucleosome-binding specificity
We previously showed that the HP1 isoform HP1a is constitutively phosphorylated by CK2 at its N-terminus, and that this phosphorylation not only enhances HP1a's binding to H3K9me3 peptide but also increases its binding specificity for H3K9me3 nucleosomes (37, 38) . To examine the effect of phosphorylation at the SR region on CBX2's binding of nucleosomes containing H3K27me3, we prepared in vitroreconstituted nucleosomes containing H3Kc 27me3 by installing a methyl-lysine analog via alkylation of a cysteine residue, and used these H3Kc27me3 nucleosomes in pull-down assays. The reconstituted nucleosomes were immobilized by biotinylated DNA on streptavidin-coated beads, and the bound CBX2-N proteins were evaluated by western blotting.
Recombinant GST-CBX2-N strongly bound H3Kc27me3 nucleosomes, and also bound control H3-unmodified (H3-unmod) nucleosomes to a lesser extent (Fig. 3A, CK2 -phos À ). Interestingly, CK2-mediated phosphorylation suppressed almost completely GST-CBX2-N's binding to the H3-unmodified CBX2 phosphorylation and its chromatin binding nucleosomes and thereby increased its nucleosomebinding specificity (Fig. 3A, CK2 -phos + ). Although this phosphorylation also reduced the GST-CBX2-N fraction bound to H3Kc27me3 nucleosomes, it is likely that the reduced fraction corresponded to a pool that bound nucleosomes without regard to H3Kc27me3. To determine whether this effect was attributable to CK2-mediated phosphorylation at the SR region, we examined the nucleosome binding of phosphorylated GST-CBX2-CD + AT, prepared with the E. coli coexpression system (Fig. 3B) , in pull-down assays.
Recombinant GST-CBX2-CD + AT robustly bound both H3-unmod and H3Kc27me3 nucleosomes (Fig.  3C) . Although a small fraction of GST-CBX2-CD + AT was phosphorylated by CK2 (Fig. 3B) , there was no noticeable change in the bound fractions. These results indicated that CK2-mediated phosphorylation at the SR region increased CBX2-N's nucleosome-binding specificity.
Phosphorylation at CBX2's SR region inhibits its nucleic acidbinding activity involving the AT-hook motif We previously showed that CK2-mediated phosphorylation increased HP1a's nucleosome-binding specificity by suppressing its intrinsic DNA-binding activity. Although CBX2-CD does not bind RNA (18) , the AThook domain is thought to bind DNA (42) and is known to contribute to CBX2's chromatin binding (30) . To further investigate the functional relationship between CK2-mediated phosphorylation and CBX2's nucleosome binding, we conducted EMSAs using a 130-bp dsDNA of major satellite repeats. The DNA probe used in this assay produced doublet bands, attributable to the number of crosslinked fluorescent dyes (see Materials and Methods).
In this assay, GST-CBX2-CD bound DNA very weakly, and a clear mobility shift was seen only at the highest input concentration of GST-CBX2-CD (Fig. 4A) . As predicted, the GST-CBX2-AT-hook alone (GST-CBX2-AT) efficiently bound DNA, and the step-wise retardation pattern indicated that multiple GST-CBX2-AT molecules bound a single DNA probe (Fig. 4B) . Compared to GST-CBX2-AT, GST-CBX2-CD + AT and GST-CBX2-N bound DNA with a slightly higher affinity (Fig. 4C, D, F and G) , suggesting that the CD or other neighboring regions somehow increased the DNA-binding activity associated with the AT-hook. Notably, CK2-mediated phosphorylation clearly inhibited GST-CBX2-N's binding of DNA (Fig. 4E) . These results support the idea that CBX-N's intrinsic DNA-binding activity enhances its H3K27me3-independent nucleosome binding, and suggest that CK2-mediated phosphorylation at CBX2's SR region inhibits CBX2-N's DNA-binding activity and increases its H3K27me3-specific nucleosome binding. These results also imply that an evolutionarily conserved mechanism involving CD, CK2-mediated phosphorylation, and intrinsic DNA-binding activity ensures CD proteins' chromatin targeting (33, 38) .
Since the AT-hook motif is found in DNA-binding proteins such as HMG-I(Y), it is thought to be an auxiliary element to support other DNA-binding activities (42) . Considering that the CD targets methylated histone tails, the physiological target of CBX2's AT-hook is likely to be nucleosomal DNA. However, there is growing evidence that CD-containing proteins also interact with cellular RNA to target specific chromosomal regions (18, 19, 39) . To test whether CBX2 binds RNA, we conducted EMSAs using an ssRNA probe (Fig. 5) .
GST-CBX2-CD bound ssRNA weakly, whereas GST-CBX2-AT, GST-CBX2-CD + AT and GST-CBX2-N strongly bound the ssRNA probe (Fig. 5AD) . The overall binding properties for Fig. 3 CK2-mediated phosphorylation of CBX2-N increases its binding specificity for H3K27me3 nucleosomes. (A) A representative nucleosome pull-down assay using synthesized nucleosomes containing unmodified H3 (H3-unmod) or H3 with a K27me3 analog (H3Kc27me3), and biotinylated 193-bp 601 DNA. Control or CK2-phosphorylated GST-CBX2-N proteins were incubated with nucleosomes immobilized on streptavidin beads, and input and recovered proteins were resolved by SDS-PAGE and analyzed by western blotting using anti-GST antibodies. (B) Control and CK2-phosphorylated GST-CBX2-CD+AT proteins prepared using an E. coli co-expression system were resolved by SDS-PAGE and visualized by CBB staining. (C) A representative nucleosome pulldown assay using control and CK2-phosphorylated GST-CBX2-CD+AT proteins. Input and recovered proteins were resolved by SDS-PAGE and analyzed by western blotting (WB) using anti-GST antibodies. ssRNA and dsDNA were comparable, although the affinities for ssRNA were slightly higher (Figs. 4G and 5G). Interestingly, CK2-mediated phosphorylation prevented GST-CBX2-N from binding ssRNA (Fig. 5E ). These results suggested that chromatinbound RNA may modulate CBX2's chromatin binding, and that CK2-mediated phosphorylation regulates CBX2's interactions with ssRNA.
The SR region and AR cluster are required for the transcriptional repression of p21 To gain insight into the physiological roles of CBX2 phosphorylation, we performed functional-restoration assays using HEK293T cells. We used specific siRNAs (siCBX2-3'UTR) to deplete the endogenous CBX2 (Fig. 6A) and examined the expression of several candidate genes targeted by PRC1 (and PRC2) (Fig. 6B ) (12, 28) . RLBP1L2 and RUNX1 loci are enriched in H3K27me3 and bound by CBX2 in HEK293T cells (12) , and CBX2 depletion led to increase the expression of these genes (Fig. 6B) . Compared with these genes, the p21 (CDKN1A) expression was more strongly affected. A previous study examining the functional role of PRC1 subunits in human hematopoiesis identified p21 as one of CBX2's target genes and demonstrated that both H3K27me3 and CBX2 are enriched at the p21 locus (28). A more recent study examining the role of a novel long non-coding RNA, APTR, identified p21 as its target genes and further demonstrated that APTR recruits PRC2 components and H3K27me3 at the p21 locus in HEK293T cells (43) . Another study analyzing epigeneome of lung adenocarcinoma cell lines showed that p21 repression states are correlated with the levels of H3K27me3 (and H3K9me3) at the p21 locus (44) . Although CBX2 might play distinct roles at these candidate target loci, we chose p21 for our functional-restoration assay as the clear derepression phenotype (Fig. 6B ) enabled us to evaluate the restoration states.
We introduced FLAG-tagged wild-type or mutant CBX2 into the CBX2-depleted cells (Fig. 6C,D) and assessed the restoration of the p21 transcriptional repression by quantitative RT-PCR (Fig. 6E) . The transcriptional repression of p21 was partially restored by wild-type CBX2 but not by mutant CBX2 lacking the SR region (CBX2-ÁSR). Mutant CBX2 lacking the CD or AR appeared to increase p21 transcription slightly, presumably due to a dominant-negative effect. These results suggested that in addition to the CD, the SR region and AR cluster are also critical for CBX2's function in vivo. Interestingly, mutant CBX2 lacking both the SR region and AR cluster (CBX2-ÁSA) partially restored the transcriptional repression of p21. The reason for this effect was unclear, but it is possible that the DNA-binding of the AT-hook in CBX2-ÁSA was alleviated by other cellular components.
Discussion
In this report, we demonstrated that CBX2 is phosphorylated predominantly at its SR region, and that this phosphorylation is critical for CBX2 to bind H3K27me3 nucleosomes. Our detailed biochemical analyses also highlighted the role of CK2-mediated phosphorylation in ensuring that CD proteins are targeted to chromatin.
A previous study reported that CBX2 in the nuclear fraction of liver tissues in mice is highly phosphorylated, and that CBX2's phosphorylation state is linked with its nuclear-cytoplasmic translocation and with cell proliferation (34) . Although a subsequent mass spectrometric analysis identified candidate phosphorylation sites in CBX2 (35) , our mutational study suggested that the SR region is the major phosphorylation site (Fig. 1) and that CK2 is most likely the kinase responsible for this phosphorylation (Fig. 2) . Once phosphorylated, serine residues adjacent to the AR cluster would mimic the acidic residues and promote the further phosphorylation of upstream serine residues. Therefore, it is likely that multiple serine residues in the SR region are non-uniformly phosphorylated in vivo, which might explain why the previous mass spectrometric analysis did not detect phosphorylated peptides in CBX2's SR region (35) . The same study also demonstrated that the phosphorylation of CBX2 at the CD changes its binding specificity for methylated H3 (35) . Although CBX2's CD was not efficiently phosphorylated by CK2 in our in vitro kinase assay (Figs. 2B and 3B), phosphorylation within the CD might function cooperatively with phosphorylation in the SR region.
In this report, we showed that the phosphorylation of CBX2 at the SR region suppressed the AT-hook's nucleic acidbinding activity and increased CBX2-N's nucleosome-binding specificity (Fig. 6F) , which was reminiscent of the role of HP1a's N-terminal phosphorylation (38) . While the interaction between phosphorylated CBX2 and reconstituted nucleosomes must reflect physiological conditions, the reason for how AT-hook motif and neighboring regions affect CBX2-CD's binding to H3K27me3 peptide remains unclear (Figs. 2D and 6F ). Since the AT-hook motif contains a series of basic residues, it might interact with CD inter-or intramolecularly and prevent CD's interaction with H3K27me3 peptide, which is also enriched in basic residues. According to this idea, phosphorylation at the SR region might change the overall structural property of charged domains and ensure the interaction between CD and H3K27me3 peptide.
The nucleic acidbinding activity associated with the AT-hook appeared to interfere with the CD's function, but recent studies revealed that AT-hook or AThook-like (ATL) motifs play important roles in CBX proteins' chromatin binding. For example, both the CD and AT-hook are required for Cbx2's targeting to pericentric heterochromatin in Suv39h-double-null mouse embryonic stem cells or in one-cell embryos (30) . In the very early mouse zygote, the AT-hook appears to play a critical role in Cbx2's H3K27me3-independent heterochromatin targeting. Furthermore, an ATL motif found in Cbx7 functions with the CD to target Cbx7 to chromatin (20) . These observations support the idea that the CD and AT-hook/ATL function cooperatively in CBX proteins' chromatin binding. We observed that although phosphorylation at the SR domain suppressed CBX2's DNA-binding activity, the phosphorylated CBX2 appeared to retain weak 0 -UTR of CBX2 mRNA (siCBX2-3'UTR) and then transfected with a control vector or a vector expressing a WT or mutant FLAG-tagged CBX2 protein. The cells were harvested 72 h after transfection, and the expression levels of transiently expressed FLAG-tagged wild-type or mutant CBX2 proteins were analyzed by western blots using anti-FLAG or anti-aÀtubulin (loading control) antibodies. (E) Quantitative RT-PCR results. The p21 mRNA levels were normalized to the -ACTIN mRNA levels, then expressed relative to the control. Error bars represent ± SD of three independent replicates. *P 5 0.05; **P 5 0.01; ***P 5 0.005. (F) Proposed model for the role of CK2-mediated phosphorylation in the chromatin binding of CBX2. Without phosphorylation, the AT-hook motif (AT) and neighboring regions suppress the CD's binding for H3K27me3 peptide and for nucleosomes (nuc.) containing H3Kc27me3. The effect of AT-hook motif on CBX2-CD's H3K27me3 peptide binding is presumably due to electrostatic interaction between CD and AT-hook motif, whereas the CBX2's nucleosome binding specificity appears to be involved with AT-hook's DNA or RNA-binding activity. Once the SR region (S) is phosphorylated, it attenuates the AT-hook's DNA/RNA binding and promotes the CD's specific binding to H3K27me3-containing nucleosomes. A: acidic-residue cluster.
DNA-binding activity. This attenuated DNA-binding might play a supportive role in CBX2's nucleosome binding. Conversely, the strong DNA-binding activity associated with the AT-hook may promote CBX2's promiscuous chromatin binding. The positively charged resides in CBX2 are critical for its ability to compact chromatin (32) . Considering that the nucleosome consists of acidic (DNA) and basic (core histone) moieties, the AR cluster embedded in the basic residues may help to loosely fix the CBX2's position relative to the nucleosome. We speculate that CBX2's phosphorylation at the SR region helps to restrict the flexibility of highly charged, intrinsically disordered regions within CBX2 and stabilize its chromatin binding, as we recently demonstrated for HP1a (45) .
The AT-hook motif is found in many DNA-binding proteins and is thought to be an auxiliary motif that cooperates with other DNA-binding activities (42) . On the other hand, we showed that CBX2's AT-hook also binds ssRNA with a slightly higher affinity than dsDNA (Figs. 4G and 5G ). Although the role of long non-coding RNAs (ncRNAs) in PRC2's chromatin targeting was recently demonstrated (43, 46) , ncRNAs' functional relationship with PRC1 or the CBX proteins is unclear. Long ncRNAs might also promote CBX2's chromatin binding or a physical interaction between PRC1 and PRC2. Although CBX2 is stably phosphorylated in cultured cells, its phosphorylation state changes dynamically in liver tissues in mice (34) . Physical interactions between CK2 and the CBX proteins may assist in changing the phosphorylation states, thereby promoting chromatin binding or triggering a switch in binding partners (36) . To further investigate CBX2's chromatin targeting, it will be important to determine how phosphorylation modulates CBX2's interaction with other proteins or nucleic acids in vivo.
